Web3

Russell 2000 stock index futures rose 0.18%.

The company stated that a patient withdrew from the trial due to a serious adverse event related to treatment and subsequently died. The death was reported in the preliminary phase 1 clinical data for patients receiving treatment for lung cancer and pancreatic cancer carrying the KRAS gene mutation. This 66-year-old male patient went to the emergency room with grade 3 pneumonia about a month after starting Erasca’s experimental therapy. Treatment was then discontinued, and the patient received related care, but unfortunately passed away. The patient had a history of cryoablation in the right lung, but no history of lung radiotherapy. Show more

Jinse Finance reported on April 28 that according to the “Q2 2026 Signals Report” released by Fidelity Digital Assets, although the cryptocurrency market is in a consolidation phase, multiple indicators are showing early signs of stabilization. The report points out that Bitcoin remains the “anchor” of the market, with capital continuing to concentrate in this most liquid asset. Its market capitalization and unrealized profit levels reflect relative resilience amid volatile conditions. Fidelity analysts state that overall, market momentum and profitability indicators align with the characteristics of a “correction phase,” potentially laying the groundwork for a more stable market structure. The report also notes a divergence between on-chain activity and price trends for Ethereum and Solana, with network demand remaining robust, indicating that the underlying protocol-level demand has not diminished. Previously, Fidelity’s global macro strategist Jurrien Timmer also expressed optimism toward Bitcoin, believing that Bitcoin is rebounding from the $60,000 low and establishing a new base near $78,000, preparing for the “next major upward wave.” Fidelity also observed that capital is rotating back from gold to Bitcoin ETPs, reversing the trend seen at the end of 2025.